Targeted Disruption of SPI3/Serpinb6 Does Not Result in Developmental or Growth Defects, Leukocyte Dysfunction, or Susceptibility to Stroke

Molecular and Cellular Biology

Volumn 24, Issue 9, 2004, Pages 4075-4082

  Scarff, Katrina L ^a   Ung, Kheng S ^a   Nandurkar, Harshal ^b   Crack, Peter J ^a   Bird, Catherina H ^a   Bird, Phillip I ^a  

^a MONASH UNIVERSITY   (Australia)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN G; LEUKOCYTE ELASTASE INHIBITOR; NEUROPSIN; PROTEIN SERPINB1; PROTEIN SERPINB6; PROTEINASE INHIBITOR 3; PROTEINASE INHIBITOR 6; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CANDIDA ALBICANS; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; ENZYME RELEASE; GENE DISRUPTION; GENE TARGETING; GROWTH RETARDATION; INFECTION; INTERNALIZATION; LEUKOCYTE DISORDER; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEAL CAVITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS; STROKE; WILD TYPE;

ANIMALS; BRAIN ISCHEMIA; CANDIDIASIS; CEREBROVASCULAR ACCIDENT; DISEASE SUSCEPTIBILITY; GENE TARGETING; HUMANS; LEUKOCYTES; MICE; MICE, KNOCKOUT; PERITONEUM; RECOMBINANT FUSION PROTEINS; SERPINS; TISSUE DISTRIBUTION;

ANIMALIA; CANDIDA; CANDIDA ALBICANS;

EID: 1942486307     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.9.4075-4082.2004     Document Type: Article

References (44)

1. Aprikyan, A. A., and D. C. Dale. 2001. Mutations in the neutrophil elastase gene in cyclic and congenital neutropenia. Curr. Opin. Immunol. 13:535-538.
2. Benarafa, C., J. Cooley, W. Zeng, P. I. Bird, and E. Remold-O'Donnell. 2002. Characterization of four murine homologs of the human ov-serpin monocyte neutrophil elastase inhibitor MNEI (SERPINB1). J. Biol. Chem. 277:42028-42033.
3. Bird, C. H., E. J. Blink, C. E. Hirst, M. S. Buzza, P. M. Steele, J. Sun, D. A. Jans, and P. I. Bird. 2001. Nucleocytoplasmic distribution of the ovalbumin serpin PI-9 requires a nonconventional nuclear import pathway and the export factor Crm1. Mol. Cell. Biol. 21:5396-5407.
4. Bird, C. H., V. R. Sutton, J. Sun, C. E. Hirst, A. Novak, J. A. Trapani, and P. I. Bird. 1998. Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol. Cell. Biol. 18:6387-6398.
5. Bird, P. I. 1999. Regulation of pro-apoptotic leucocyte granule serine proteinases by intracellular serpins. Immunol. Cell Biol. 77:47-57.
6. Blasi, E., L. Pitzurra, A. R. Chimienti, R. Mazzolla, M. Puliti, R. Barluzzi, and F. Bistoni. 1995. Differential susceptibility of yeast and hyphal forms of Candida albicans to proteolytic activity of macrophages. Infect. Immun. 63:1253-1257.
7. Chertov, O., H. Ueda, L. L. Xu, K. Tani, W. J. Murphy, J. M. Wang, O. M. Z. Howard, T. J. Sayers, and J. J. Oppenheim. 1997. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J. Exp. Med. 186:739-747.
8. Cinelli, P., R. Madani, N. Tsuzuki, P. Vallet, M. Arras, C. N. Zhao, T. Osterwalder, T. Rulicke, and P. Sonderegger. 2001. Neuroserpin, a neuro-protective factor in focal ischemic stroke. Mol. Cell. Neurosci. 18:443-457.
9. Cohen, R. J., J. E. McNeal, S. G. Edgar, T. Robertson, and H. J. Dawkins. 1998. Characterization of cytoplasmic secretory granules (PSG), in prostatic epithelium and their transformation-induced loss in dysplasia and adenocarcinoma. Hum. Pathol. 29:1488-1494.
10. Coughlin, P., J. Sun, L. Cerruti, H. H. Salem, and P. Bird. 1993. Cloning and molecular characterization of a human intracellular proteinase inhibitor. Proc. Natl. Acad. Sci. USA 90:9417-9421.
11. Crack, P. J., J. M. Taylor, N. J. Flentjar, J. de Haan, P. Hertzog, R. C. Ianello, and I. Kola. 2001. Increased infarct size and exacerbated apoptosis in the glutathione peroxidase-1 (gpx-1) knockout mouse brain in response to ischemia/reperfusion injury. J. Neurochem. 78:1389-1399.
12. Cutler, J. E. 1991. Putative virulence factors of Candida albicans. Annu. Rev. Microbiol. 45:187-218.
13. Darnell, G. A., T. M. Antalis, R. W. Johnstone, B. W. Stringer, S. M. Ogbourne, D. Harrich, and A. Suhrbier. 2003. Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif. Mol. Cell. Biol. 23:6520-6532.
14. Davies, A. F., G. Mirza, G. Sekhon, P. Turnpenny, F. Leroy, F. Speleman, C. Law, N. van Regemorter, E. Vamos, F. Flinter, and J. Ragoussis. 1999. Delineation of two distinct 6p deletion syndromes. Hum. Genet. 104:64-72.
15. Dougherty, K. M., J. M. Pearson, A. Y. Yang, R. J. Westrick, M. S. Baker, and D. Ginsburg. 1999. The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival. Proc. Natl. Acad. Sci. USA 96:686-691.
16. Edens, H. A., C. A. Parkos, T. W. Liang, A. J. Jesaitis, J. E. Cutler, and H. M. Miettinen. 1999. Non-serum-dependent chemotactic factors produced by Candida albicans stimulate chemotaxis by binding to the formyl peptide receptor on neutrophils and to an unknown receptor on macrophages. Infect. Immun. 67:1063-1071.
17. Hirata, A., S. Yoshida, N. Inoue, K. Matsumoto-Miyai, A. Ninomiya, M. Taniguchi, T. Matsuyama, K. Kato, H. Iizasa, Y. Kataoka, N. Yoshida, and S. Shiosaka. 2001. Abnormalities of synapses and neurons in the hippocampus of neuropsin-deficient mice. Mol. Cell. Neurosci. 17:600-610.
18. Hirst, C. E., M. S. Buzza, C. H. Bird, H. S. Warren, P. U. Cameron, M. Zhang, P. G. Ashton-Rickhardt, and P. I. Bird. 2003. The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency. J. Immunol. 170:805-815.
19. Hirst, C. E., M. S. Buzza, V. R. Sutton, J. A. Trapani, K. L. Loveland, and P. I. Bird. 2001. Perforin-independent expression of granzyme B and proteinase inhibitor 9 in human testis and placenta suggests a role for granzyme B-mediated proteolysis in reproduction. Mol. Hum. Reprod. 7:1133-1142.
20. Huntington, J. A., R. A. Read, and R. W. Carrell. 2000. Structure of a serpin-protease complex shows inhibition by deformation. Nature 407:923-926.
21. Irving, J. A., R. N. Pike, A. M. Lesk, and J. C. Whisstock. 2000. Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res. 10:1845-1864.
22. Jensen, J., T. Warner, and E. Balish. 1993. Resistance of SCID mice to Candida albicans administered intravenously or colonizing the gut: role of polymorphonuclear leukocytes and macrophages. J. Infect. Dis. 167:912-919.
23. Kaiserman, D., S. Knaggs, K. L. Scarff, A. Gillard, G. Mirza, M. Cadman, R. McKeone, P. Denny, J. Cooley, C. Benarafa, E. Remold-O'Donnell, J. Ragoussis, and P. I. Bird. 2002. Comparison of human chromosome 6p25 with murine chromosome 13 reveals a greatly expanded ov-serpin gene repertoire in the mouse. Genomics 79:349-362.
24. Kato, K., T. Kishi, T. Kamachi, M. Akisada, T. Oka, R. Midorikawa, K. Takio, N. Dohmae, P. Bird, J. Sun, F. Scott, Y. Miyake, K. Yamamoto, A. Machida, T. Tanaka, K. Matsumoto, M. Shibata, and S. Shiosaka. 2001. Serine proteinase inhibitor 3 and murinoglobulin I are potent inhibitors of neuropsin in adult mouse brain. J. Biol. Chem. 276:14562-14571.
25. Kishi, T., P. Matsuhashi, P. I. Bird, and K. Kato. 2002. Distribution of serine proteinase inhibitor, clade B, member 6 (Serpinb6) in the adult mouse brain. Gene Expr. Patterns 1:175-180.
26. Kullberg, B. J., M. G. Netea, A. G. Vonk, and J. W. van der Meer. 1999. Modulation of neutrophil function in host defense against disseminated Candida albicans infection in mice. FEMS Immunol. Med. Microbiol. 26:299-307.
27. Levesque, J. P., J. Hendy, Y. Takamatsu, B. Williams, I. G. Wingler, and P. J. Simmons. 2002. Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. Exp. Hematol. 30:440-449.
28. Li, X., and G. R. Stark. 2002. NFkappaB-dependent signaling pathways. Exp. Hematol. 30:285-296.
29. Loyola, W., D. A. Gaziri, L. C. Gaziri, and I. Felipe. 2002. Concanavalin A enhances phagocytosis and killing of Candida albicans by mice peritoneal neutrophils and macrophages. FEMS Immunol. Med. Microbiol. 33:201-208.
30. Mikolajczyk, S. D., L S. Millar, K. M. Marker, H. G. Rittenhouse, R. L. Wolfert, L S. Marks, M. C. Charlesworth, and D. J. Tindall. 1999. Identification of a novel complex between human kallikrein 2 and proteinase inhibitor-6 in prostate cancer tissue. Cancer Res. 59:3927-3930.
31. Nakaya, N., M. Nishibori, Z. Wang, J. Sakiyama, and K. Saeki. 1998. The expression and localization of serine proteinase inhibitor PI-6 mRNA in developmental and ischemic mouse brain. Neurosci. Res. 32:221-230.
32. Qian, Q., M. A. Jutila, N. van Rooijen, and J. E. Cutler. 1994. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J. Immunol. 152:5000-5008.
33. Scarff, K. L., K. S. Ung, J. Sun, and P. I. Bird. 2003. A retained selection cassette increases reporter gene expression without affecting tissue distribution in SPI3 knockout/GFP knock-in mice. Genesis 36:149-157.
34. Schwenk, F., U. Baron, and K. Rajewsky. 1995. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23:5080-5081.
35. Scott, F. L., P. B. Coughlin, C. Bird, L. Cerruti, J. A. Hayman, and P. Bird. 1996. Proteinase inhibitor 6 cannot be secreted, which suggests it is a new type of cellular serpin. J. Biol. Chem. 271:1605-1612.
36. Scott, F. L., H. J. Eyre, M. Lioumi, J. Ragoussis, J. A. Irving, G. A. Sutherland, and P. I. Bird. 1999. Human ovalbumin serpin evolution: phylogenic analysis, gene organization, and identification of new PI-8-related genes suggest that two interchromosomal and several intrachromosomal duplications generated the gene clusters at 18q21-q23 and 6p25. Genomics 62:490-499.
37. Scott, F. L., C. E. Hirst, J. Sun, S. P. Bottomley, C. H. Bird, and P. I. Bird. 1999. The intracellular serpin proteinase inhibitor 6 (PI-6) is expressed in monocytes and granulocytes and is a potent inhibitor of the azurophilic granule proteinase, cathepsin G. Blood 93:2089-2097.
38. Shimizu-Okabe, C., G. M. Yousef, E. P. Diamandis, S. Yoshida, S. Shiosaka, and M. Fahnestock. 2001. Expression of the kallikrein gene family in normal and Alzheimer's disease brain. Neuroreport 12:2747-2751.
39. Silverman, G. A., P. I. Bird, R. W. Carrell, F. C. Church, P. B. Coughlin, P. G. W. Gettins, J. A. Irving, D. A. Lomas, C. J. Luke, R. W. Moyer, P. A. Pemberton, E. Remold-O'Donnell, G. S. Salvesen, J. Travis, and J. C. Whisstock. 2001. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. J. Biol. Chem. 276:33293-33296.
40. Stein, P. E., and R. W. Carrell. 1995. What do dysfunctional serpins tell us about molecular mobility and disease. Struct. Biol. 2:96-113.
41. Vonk, A. G., C. W. Wieland, M. G. Netea, and B. J. Kullberg. 2002. Phagocytosis and intracellular killing of Candida albicans blastoconidia by neutrophils and macrophages: a comparison of different microbiological test systems. J. Microbiol. Methods 49:55-62.
42. Yepes, M., M. Sandkvist, M. K. K. Wong, T. A. Coleman, S. Smith, S. L. Cohan, and D. A. Lawrence. 2001. Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood 96:569-576.
43. Zeng, W., and E. Remold-O'Donnell. 2000. Human monocyte/neutrophil elastase inhibitor (MNEI) is regulated by PU.1/Spi-1, Sp1, and NF-kappaB. J. Cell. Biochem. 78:519-532.
44. Zhou, Q., and G. S. Salvesen. 1997. Activation of pro-caspase-7 by serine proteases includes a non-canonical specificity. Biochem. J. 324:361-364.